Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 0.0 | 0.0 | 0.0 | 0.0 |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 |
| Research and development | 28.0 | 15.5 | 9.4 | 10.5 |
| General and administrative | 51.6 | 16.5 | 4.5 | 4.8 |
| EBITA | -54.0 | -31.9 | -13.8 | -15.2 |
| Amortization of intangibles | 0.1 | 0.1 | 0.1 | 0.1 |
| EBIT | -54.1 | -32.0 | -13.9 | -15.3 |
| Pre-tax income | -49.7 | -31.2 | -13.9 | -14.6 |
| Income taxes | 1.3 | 0.0 | 0.0 | 0.1 |
| Net income | -51.0 | -31.3 | -13.9 | -14.7 |
| |
| Diluted EPS | ($0.18) | ($0.51) | ($0.23) | ($1.44) |
| Shares outstanding (diluted) | 288.3 | 61.1 | 60.8 | 10.2 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|